Similar articles for PMID: 18335668

Year	Number of Results
1995	1
1996	2
1999	1
2000	6
2001	3
2002	1
2003	4
2004	7
2005	4
2006	12
2007	7
2008	13
2009	6
2010	11
2011	6
2012	7
2013	1
2014	9
2015	4
2017	1
2021	0

1

Recent developments in acute coronary syndromes.

Iqbal MB, Westwood MA, Swanton RH. Iqbal MB, et al. Clin Med (Lond). 2008 Feb;8(1):42-8. doi: 10.7861/clinmedicine.8-1-42. Clin Med (Lond). 2008. PMID: 18335668 Free PMC article. Review.

2

Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.

Kwa AT, Rogers JH. Kwa AT, et al. J Interv Cardiol. 2008 Apr;21(2):107-17. doi: 10.1111/j.1540-8183.2007.00335.x. Epub 2008 Jan 30. J Interv Cardiol. 2008. PMID: 18248357 Free article. Review.

3

Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.

Saw J, Lincoff AM, DeSmet W, Betriu A, Rutsch W, Wilcox RG, Kleiman NS, Wolski K, Topol EJ; REPLACE-2 Investigators. Saw J, et al. J Am Coll Cardiol. 2004 Sep 15;44(6):1194-9. doi: 10.1016/j.jacc.2004.06.049. J Am Coll Cardiol. 2004. PMID: 15364319 Free article. Clinical Trial.

4

2007 Guideline update for unstable angina/non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies.

Coons JC, Battistone S. Coons JC, et al. Ann Pharmacother. 2008 Jul;42(7):989-1001. doi: 10.1345/aph.1L063. Epub 2008 Jun 24. Ann Pharmacother. 2008. PMID: 18577763

5

The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention.

Wang TY, Magid DJ, Ting HH, Li S, Alexander KP, Roe MT, Peterson ED. Wang TY, et al. Am Heart J. 2014 Jun;167(6):833-9. doi: 10.1016/j.ahj.2014.03.002. Epub 2014 Mar 14. Am Heart J. 2014. PMID: 24890532

6

Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors.

Bangalore S, Toklu B, Kotwal A, Volodarskiy A, Sharma S, Kirtane AJ, Feit F. Bangalore S, et al. BMJ. 2014 Nov 11;349:g6419. doi: 10.1136/bmj.g6419. BMJ. 2014. PMID: 25389143 Free PMC article.

7

Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial.

Rajagopal V, Lincoff AM, Cohen DJ, Gurm HS, Hu T, Desmet WJ, Kleiman NS, Bittl JA, Feit F, Topol EJ. Rajagopal V, et al. Am Heart J. 2006 Jul;152(1):149-54. doi: 10.1016/j.ahj.2005.09.007. Am Heart J. 2006. PMID: 16824845

8

Acute myocardial infarction 2000 treatment.

Wehrmacher WH. Wehrmacher WH. Compr Ther. 2001 Fall;27(3):228-31. doi: 10.1007/s12019-001-0019-z. Compr Ther. 2001. PMID: 11569324

9

Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?

Di Sciascio G, Mangiacapra F. Di Sciascio G, et al. J Am Coll Cardiol. 2012 Jul 31;60(5):378-80. doi: 10.1016/j.jacc.2012.03.033. Epub 2012 Jun 6. J Am Coll Cardiol. 2012. PMID: 22682552 Free article. No abstract available.

10

Managing acute coronary syndrome: evidence-based approaches.

Spinler SA. Spinler SA. Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S14-24. doi: 10.2146/ajhp070109. Am J Health Syst Pharm. 2007. PMID: 17519441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed